Skip to main content

Table 2 Prevalence of morbidities and of multimorbidity at different cutoffs, ELSA-Brasil baseline

From: Racial inequalities in multimorbidity: baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Baseline characteristicsa

Overall (%)b

Race/skin colour (%)b

p Valuec

White

Mixed-race

Black

Morbidities

 Dyslipidaemia

  No

7637 (54.17)

4020 (52.81)

2291 (55.55)

1326 (56.12)

0.002

  Yes

6462 (45.83)

3592 (47.19)

1833 (44.45)

1037 (43.88)

 

 Arterial hypertension

  No

9042 (64.13)

5238 (68.81)

2591 (62.83)

1213 (51.33)

 < 0.001

  Yes

5057 (35.87)

2374 (31.19)

1533 (37.17)

1150 (48.67)

 

 Migraine

  No

9921 (70.37)

5425 (71.27)

2877 (69.76)

1619 (68.51)

0.023

  Yes

4178 (29.63)

2187 (28.73)

1247 (30.24)

744 (31.49)

 

 Common mental disorders

  No

10 320 (73.20)

5845 (76.79)

2861 (69.37)

1614 (68.30)

 < 0.001

  Yes

3779 (26.80)

1767 (23.31)

1263 (30.63)

749 (31.70)

 

 Obesity

  No

10 863 (77.05)

6025 (79.15)

3182 (77.16)

1656 (70.08)

 < 0.001

  Yes

3236 (22.95)

1587 (20.85)

942 (22.84)

707 (29.92)

 

 Joint disorders

  No

11 065 (78.48)

6092 (80.03)

3197 (77.52)

1776 (75.16)

 < 0.001

  Yes

3034 (21.52)

1520 (19.97)

927 (22.48)

587 (24.84)

 

 Renal disease

  No

11 616 (82.39)

6041 (79.36)

3469 (84.12)

2106 (89.12)

 < 0.001

  Yes

2483 (17.61)

1571 (20.64)

655 (15.88)

257 (10.88)

 

 Diabetes

  No

11 866 (84.16)

6602 (86.73)

3445 (83.54)

1819 (76.98)

 < 0.001

  Yes

2233 (15.84)

1010 (13.27)

679 (16.46)

544 (23.02)

 

 Asthma

  No

12 457 (88.35)

6696 (87.97)

3674 (89.09)

2087 (88.32)

0.194

  Yes

1642 (11.65)

916 (12.03)

450 (10.91)

276 (11.68)

 

 Liver cirrhosis or hepatitis

  No

12 886 (91.40)

6817 (89.56)

3843 (93.19)

2226 (94.20)

 < 0.001

  Yes

1213 (8.60)

795 (10.44)

281 (6.81)

137 (5.80)

 

 Cancer

  No

13 449 (95.39)

7151 (93.94)

3996 (96.90)

2302 (97.42)

 < 0.001

  Yes

650 (4.61)

461 (6.06)

128 (3.10)

61 (2.58)

 

 Ischemic heart disease

  No

13 482 (95.62)

7297 (95.86)

3949 (95.76)

2236 (94.63)

0.033

  Yes

617 (4.38)

315 (4.14)

175 (4.24)

127 (5.37)

 

 Rheumatic fever

  No

13 697 (97.15)

7389 (97.07)

4003 (97.07)

2305 (97.55)

0.446

  Yes

402 (2.85)

223 (2.93)

121 (2.93)

58 (2.45)

 

 Emphysema, chronic bronchitis or COPD

  No

13 819 (98.01)

7426 (97.56)

4063 (98.52)

2330 (98.60)

 < 0.001

  Yes

280 (1.99)

186 (2.44)

61 (1.48)

33 (1.40)

 

 Cardiac insufficiency

  No

13 871 (98.38)

7519 (98.78)

4051 (98.23)

2301 (97.38)

 < 0.001

  Yes

228 (1.62)

93 (1.22)

73 (1.77)

62 (2.62)

 

 Cerebrovascular accident

  No

13 920 (98.01)

7526 (98.87)

4068 (98.52)

2326 (98.43)

0.213

  Yes

179 (1.27)

86 (1.13)

61 (1.48)

37 (1.57)

 

Multimorbidity cutoff

 ≥ 2 morbidities

  No

4217 (29.91)

2409 (31.65)

1210 (29.34)

598 (25.31)

 < 0.001

  Yes

9882 (70.09)

5203 (68.35)

2914 (70.66)

1765 (74.69)

 

 ≥ 3 morbidities

  No

7620 (54.05)

4254 (55.89)

2233 (54.15)

1133 (47.95)

 < 0.001

  Yes

6479 (45.95)

3358 (44.11)

1891 (45.85)

1230 (52.05)

 

 ≥ 4 morbidities

    No

10 484 (74.36)

5789 (76.05)

3075 (74.56)

1620 (68.56)

 < 0.001

    Yes

3615 (25.64)

1823 (23.95)

1049 (25.44)

743 (31.44)

 

 ≥ 5 morbidities

  No

12 360 (87.67)

6742 (88.57)

3626 (87.92)

1992 (84.30)

 < 0.001

  Yes

1739 (12.33)

870 (11.43)

498 (12.08)

371 (15.70)

 

 ≥ 6 morbidities

  No

13 359 (94.75)

7255 (95.31)

3902 (94.62)

2202 (93.19)

 < 0.001

  Yes

740 (5.25)

357 (4.69)

222 (5.38)

161 (6.81)

 

 Number of morbidities

  Mean (standard deviation)

2.53 (1.69)

2.45 (1.65)

2.53 (1.69)

2.78 (1.78)

 < 0.001

  Median (1st—3rd quartile)

2 (1—4)

2 (1—3)

2 (1—4)

3 (1—4)

 
  1. COPD chronic obstructive pulmonary disease
  2. aN for all characteristics was 14 099
  3. bPercentages within each race/skin colour group or overall estimate (sum 100% in the column), except for the numerical variable age for which mean, standard deviation, median, 1st and 3rd quartile are given and the total number of participants that adds up to 100% on the line
  4. cRefers to the X2 test for difference in percentages and Kruskal–Wallis test for number of morbidities between race/skin colour groups